SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-127382
Filing Date
2023-04-28
Accepted
2023-04-28 16:47:58
Documents
3
Period of Report
2023-07-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d428853ddef14a.htm DEF 14A 343945
2 GRAPHIC g428853g01n01.jpg GRAPHIC 176644
3 GRAPHIC g428853g02n02.jpg GRAPHIC 92172
  Complete submission text file 0001193125-23-127382.txt   704154
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39617 | Film No.: 23867558
SIC: 2836 Biological Products, (No Diagnostic Substances)